PRO MEDICUS LIMITED — Director's Dealing 2023

Mar 13, 2023

==> picture [136 x 51] intentionally omitted <==

Pro Medicus Limited 450 Swan Street Richmond Victoria 3121 Australia T +61 3 9429 8800 F +61 3 9429 9455 www.promed.com.au

Company announcement Sale of Shares by Chairman

14 March 2023

The Chairman of the Board, Mr. Peter T Kempen AM, has advised that his superannuation fund has sold 50,000 PME shares during the current trading window. (Refer Change of Director’s Interest Notice).

The sale was part of a rebalancing of the superannuation fund’s portfolio interests. No further sales by interests associated with Mr. Kempen are contemplated in the foreseeable future.

Mr. Kempen’s combined interests in the Company after the sale total 629,082 shares representing approximately 0.6% of the Company’s shares on issue.

This announcement is authorised by the Chairman of the Board.

For further information:

Dr Sam Hupert Chief Executive Officer Pro Medicus Limited Ph: +61 3 9429 8800

About Pro Medicus Limited:

Pro Medicus Limited [ASX: PME] is a leading healthcare informatics company. Founded in 1983, the company provides a full range of medical imaging software and services to hospitals, imaging centres and health care groups worldwide. In January 2009, the company acquired Visage Imaging transforming it into a global provider of leading-edge medical imaging solutions. The company’s Visage 7 suite of products are the foundation of an ultra-fast, clinically rich, and highly scalable platform that can seamlessly be implemented in both public and private cloud environments. The company offers a leading suite of RIS, PACS, Artificial Intelligence (AI) and e-health solutions constituting one of the most comprehensive end-to-end offerings in healthcare imaging. Pro Medicus has offices in Melbourne, Berlin and San Diego. www.promedicus.com.au

Pro Medicus Limited ABN 25 006 194 752